文献速递主动脉疾病

B型主动脉夹层的病因特异性死亡率及竞争风险分析

Cause-specific mortality of type B aortic dissection and assessment of competing risks of mortality.
PubMed 文献 · J Vasc Surg · 2020-05-11

本研究回顾1995-2017年275例急性B型主动脉夹层患者,通过多模式方法确定死因,并采用Fine-Gray竞争风险模型分析。结果显示10年全因死亡率为57%,主动脉相关死亡累积发生率为27.2%,降主动脉最大直径>4 cm与主动脉相关死亡风险增加84%相关。

要点

  • B型主动脉夹层10年全因死亡率达57%,主动脉相关死亡占51%。
  • 降主动脉最大直径>4 cm使主动脉相关死亡风险增加84%。
  • 主动脉相关死亡患者更年轻、接受降主动脉修复更多、生存期更短。

核心结论

  • B型主动脉夹层与高10年死亡率相关。
  • 主动脉相关死亡与非主动脉相关死亡的风险人群具有不同临床表型。
  • 该信息有助于构建考虑竞争死亡风险的风险预测模型,并指导个体化治疗。

研究设计与样本

  • 回顾性队列研究,纳入1995-2017年275例急性B型主动脉夹层患者。
  • 通过电子健康记录、讣告、社交媒体、社会保障死亡索引和州死亡记录等多模式方法确定死因。
  • 采用Fine-Gray多变量竞争风险回归模型分析临床特征与主动脉相关及非主动脉相关死亡的关联。

主要发现

  • 平均出院后生存时间为6.3±4.7年,随访完整性Clark C指数为0.87。
  • 全因死亡率为50.2%(n=138;平均年龄70.1±14.6岁),院内死亡率为8.4%。
  • 死因分类:主动脉相关51%,非主动脉相关43%,未知6%。
  • 主动脉相关死亡患者相比非主动脉相关死亡患者:急性TBAD时更年轻(69.5±11.2岁 vs 61.6±15.5岁;P=.001),接受降主动脉修复更多(19.4% vs 45.8%;P=.002),生存时间更短(5.7±3.9 vs 3.4±4.5年;P=.002)。
  • 按年龄每十年分层,死因有明显变化:<50岁和>70岁者主动脉相关死亡率更高,非主动脉相关死亡率随年龄每增加十年逐步上升(P<.001)。

临床怎么用

  • 应关注B型主动脉夹层患者的长期死因,区分主动脉相关与非主动脉相关死亡风险。
  • 对于降主动脉最大直径>4 cm的患者,需加强主动脉相关死亡的监测和干预。
  • 年龄<50岁或>70岁患者主动脉相关死亡风险较高,应个体化制定随访和治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Natural history studies of type B aortic dissection (TBAD) commonly report all-cause mortality. Our aim was to determine cause-specific mortality in TBAD and to evaluate the clinical characteristics associated with aorta-related and nonaorta-related mortality. METHODS: Clinical and administrative records were reviewed for patients with acute TBAD between 1995 and 2017. Demographics, comorbidities, presentation, and initial imaging findings were abstracted. Cause of death was ascertained through a multimodality approach using electronic health records, obituaries, social media, Social Security Death Index, and state mortality records. Causes of death were classified as aorta related, nonaorta related, or unknown. A Fine-Gray multivariate competing risk regression model for subdistribution hazard ratio was employed to analyze the association of clinical characteristics with aorta-related and nonaorta-related mortality. RESULTS: A total of 275 individuals met inclusion criteria (61.1 ± 13.7 years, 70.9% male, 68% white). Mean survival after discharge was 6.3 ± 4.7 years. Completeness of follow-up Clark C index was 0.87. All-cause mortality was 50.2% (n = 138; mean age, 70.1 ± 14.6 years) including an in-hospital mortality of 8.4%. Cause-specific mortality was aorta related, nonaorta related, and unknown in 51%, 43%, and 6%, respectively. Compared with patients with nonaorta-related mortality, patients with aorta-related mortality were younger at acute TBAD (69.5 ± 11.2 years vs 61.6 ± 15.5 years; P = .001), underwent more descending thoracic aortic repairs (19.4% vs 45.8%; P = .002), and had a shorter survival duration (5.7 ± 3.9 vs 3.4 ± 4.5 years; P = .002). There was clear variation in cause of death by each decade of life, with higher aorta-related mortality among those younger than 50 years and older than 70 years and a stepwise increase in nonaorta-related mortality with each increasing decade (P < .001). All-cause mortality at 1 year, 3 years, and 10 years was 15%, 24%, and 57%, respectively. After accounting for competing risks, the cumulative incidence of aorta-related mortality at 1 year, 3 years, and 10 years was 8.9%, 16.5%, and 27.2%, respectively, and that of nonaorta-related mortality was 2.7%, 7.2%, and 29%, respectively. A maximum descending thoracic aortic diameter >4 cm was associated with an increase in hazard of aorta-related mortality by 84% (subdistribution hazard ratio, 1.84; 95% confidence interval, 1.03-3.28) on multivariate competing risk regression analysis. CONCLUSIONS: TBAD is associated with high 10-year mortality. Those at risk for aorta-related mortality have a clinical phenotype different from that of individuals at risk for nonaorta-related mortality. This information is important for building risk prediction models that account for competing mortality risks and to direct optimal and individualized surgical and medical management of TBAD.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hysa L, Khor S, Starnes BW, et al. Cause-specific mortality of type B aortic dissection and assessment of competing risks of mortality. J Vasc Surg. 2020. PMID: 32437949. doi:10.1016/j.jvs.2020.04.499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。